These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8270496)

  • 61. Design and synthesis of new vancomycin derivatives.
    Gu W; Chen B; Ge M
    Bioorg Med Chem Lett; 2014 May; 24(10):2305-8. PubMed ID: 24751442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.
    Groves P; Searle MS; Mackay JP; Williams DH
    Structure; 1994 Aug; 2(8):747-54. PubMed ID: 7994574
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE; Nicas TI
    FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
    Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
    J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Eremomycin--new glycopeptide antibiotic: chemical properties and structure.
    Gause GF; Brazhnikova MG; Lomakina NN; Berdnikova TF; Fedorova GB; Tokareva NL; Borisova VN; Batta GY
    J Antibiot (Tokyo); 1989 Dec; 42(12):1790-7. PubMed ID: 2621162
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and Synthesis of Pyrophosphate-Targeting Vancomycin Derivatives for Combating Vancomycin-Resistant Enterococci.
    Guan D; Chen F; Faridoon ; Liu J; Li J; Lan L; Huang W
    ChemMedChem; 2018 Aug; 13(16):1644-1657. PubMed ID: 29920964
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
    Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
    Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycopeptide carboxamides active against vancomycin-resistant enterococci.
    Zweifel MJ; Snyder NJ; Cooper RD; Nicas TI; Mullen DL; Butler TF; Rodriguez MJ
    J Antibiot (Tokyo); 2003 Mar; 56(3):289-95. PubMed ID: 12760685
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enzymatic synthesis of vancomycin derivatives using galactosyltransferase and sialyltransferase.
    Oh TJ; Kim DH; Kang SY; Yamaguchi T; Sohng JK
    J Antibiot (Tokyo); 2011 Jan; 64(1):103-9. PubMed ID: 21119677
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
    J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.
    Okano A; Isley NA; Boger DL
    Chem Rev; 2017 Sep; 117(18):11952-11993. PubMed ID: 28437097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
    Crane CM; Boger DL
    J Med Chem; 2009 Mar; 52(5):1471-6. PubMed ID: 19209892
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bromobalhimycin and chlorobromobalhimycins--illuminating the potential of halogenases in glycopeptide antibiotic biosyntheses.
    Bister B; Bischoff D; Nicholson GJ; Stockert S; Wink J; Brunati C; Donadio S; Pelzer S; Wohlleben W; Süssmuth RD
    Chembiochem; 2003 Jul; 4(7):658-62. PubMed ID: 12851938
    [No Abstract]   [Full Text] [Related]  

  • 77. Synthesis and antibacterial activity of derivatives of the glycopeptide antibiotic A-40926 and its aglycone.
    Hermann R; Ripamonti F; Romanò G; Restelli E; Ferrari P; Goldstein BP; Berti M; Ciabatti R
    J Antibiot (Tokyo); 1996 Dec; 49(12):1236-48. PubMed ID: 9031670
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A facile Fmoc solid phase synthesis strategy to access epimerization-prone biosynthetic intermediates of glycopeptide antibiotics.
    Brieke C; Cryle MJ
    Org Lett; 2014 May; 16(9):2454-7. PubMed ID: 24730694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
    Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemical modification of the eremomycin antibiotic. Formation of a cyclic covalent dimer.
    Sztaricskai F; Batta G; Dinya Z; Miroshnikova OV; Preobrazhenskaya MN; Hernádi F; Koncz A; Boda Z
    J Antibiot (Tokyo); 2001 Mar; 54(3):314-9. PubMed ID: 11372789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.